JS1-1-01

· Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JS1-1-01, covering 2024-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression [Phase 2]